Genetic Analysis of Oculocerebrorenal Syndrome of Lowe

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 17, 2001

Study Completion Date

February 3, 2009

Conditions
Lowe Syndrome
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT00359515 - Genetic Analysis of Oculocerebrorenal Syndrome of Lowe | Biotech Hunter | Biotech Hunter